Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptor.

Virotherapy of ovarian cancer with polymer-cloaked adenovirus retargeted to the epidermal growth factor receptor.

Adenovirus gene therapy for intraperitoneal (IP) cancer is limited in clinical trials by inefficient tumor cell transduction and development of peritoneal adhesions. We have shown previously that normal virus tropism can be ablated by physically shielding the virus surface with reactive hydrophilic...

Detaylı Bibliyografya
Asıl Yazarlar:	Morrison, J, Briggs, S, Green, N, Fisher, K, Subr, V, Ulbrich, K, Kehoe, S, Seymour, L
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2008

Benzer Materyaller

Cetuximab retargeting of adenovirus via the epidermal growth factor receptor for treatment of intraperitoneal ovarian cancer.
Yazar:: Morrison, J, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Retargeting adenovirus gene therapy via the epidermal growth factor receptor
Yazar:: Morrison, J, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Retargeting polymer-coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancer.
Yazar:: Green, N, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies
Yazar:: Fisher, K, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

E-selectin is a viable route of infection for polymer-coated adenovirus retargeting in TNF-α-activated human umbilical vein endothelial cells.
Yazar:: Bachtarzi, H, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Tropism ablation and stealthing of oncolytic adenovirus enhances systemic delivery to tumors and improves virotherapy of cancer.
Yazar:: Green, N, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Passive tumour targeting of polymer-coated adenovirus for cancer gene therapy.
Yazar:: Fisher, K, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Coating of adeno-associated virus with reactive polymers can ablate virus tropism, enable retargeting and provide resistance to neutralising antisera.
Yazar:: Carlisle, R, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Improving intraperitoneal adenovirus virotherapy for ovarian cancer
Yazar:: Thoma, CMM
Baskı/Yayın Bilgisi: (2011)

Enhanced tumor uptake and penetration of virotherapy using polymer stealthing and focused ultrasound.
Yazar:: Carlisle, R, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Decreased binding to proteins and cells of polymeric gene delivery vectors surface modified with a multivalent hydrophilic polymer and retargeting through attachment of transferrin
Yazar:: Dash, P, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Coating of adenovirus type 5 with polymers containing quaternary amines prevents binding to blood components.
Yazar:: Subr, V, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1
Yazar:: Carlisle, R, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1.
Yazar:: Carlisle, R, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Optimally stealthed Adenovirus serotype 5 shows enhanced activity and resistance to neutralisation
Yazar:: Thoma, C, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

The effect of polymer coating and different adenovirus serotypes on the innate immune responses to intraperitoneal adenovirus
Yazar:: Thoma, C, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Adenovirus type 5 (Ad5) is sequestered and inactivated by binding to coxsackievirus and adenovirus receptor (CAR) and complement receptor 1 (CR1) on human erythrocytes
Yazar:: Carlisle, R, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Comparison of molecular strategies for breast cancer virotherapy using oncolytic adenovirus.
Yazar:: Bazan-Peregrino, M, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

HPMA copolymers for masking and retargeting of therapeutic viruses.
Yazar:: Fisher, K, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Targeting adenovirus gene delivery to activated tumour-associated vasculature via endothelial selectins.
Yazar:: Bachtarzi, H, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Polymer stealthing and mucin-1 retargeting for enhanced pharmacokinetics of an oncolytic vaccinia virus
Yazar:: Hill, C, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Virotherapy - Cancer targeted pharmacology
Yazar:: Tedcastle, A, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Virotherapy--cancer targeted pharmacology.
Yazar:: Tedcastle, A, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Polymer stealthing and mucin-1 retargeting for enhanced pharmacokinetics of an oncolytic vaccinia virus
Yazar:: Claudia Hill, ve diğerleri
Baskı/Yayın Bilgisi: (2021-06-01)

Use of synthetic vectors for neutralising antibody resistant delivery of replicating adenovirus DNA.
Yazar:: Carlisle, R, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Glycoviruses: chemical glycosylation retargets adenoviral gene transfer.
Yazar:: Pearce, O, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Defining a murine ovarian cancer model for the evaluation of conditionally-replicative adenovirus (CRAd) virotherapy agents
Yazar:: Rebeca González-Pastor, ve diğerleri
Baskı/Yayın Bilgisi: (2019-02-01)

Evaluation of polymer shielding for adenovirus serotype 6 (Ad6) for systemic virotherapy against human prostate cancers
Yazar:: Tien V Nguyen, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

Novel Infectivity-Enhanced Oncolytic Adenovirus with a Capsid-Incorporated Dual-Imaging Moiety for Monitoring Virotherapy in Ovarian Cancer
Yazar:: Kristopher J. Kimball, ve diğerleri
Baskı/Yayın Bilgisi: (2009-09-01)

The Feasibility of Pressurised Intraperitoneal Aerosolised Virotherapy (PIPAV) to Administer Oncolytic Adenoviruses
Yazar:: Sophia J. Tate, ve diğerleri
Baskı/Yayın Bilgisi: (2021-11-01)

Ultrasound-enhanced delivery of polymer-coated oncolytic adenovirus for tumour growth inhibition
Yazar:: Carlisle, R, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Epidermal growth factor receptor blockers for the treatment of ovarian cancer
Yazar:: Morrison, J, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy
Yazar:: Mahasa, K, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Biodistribution Analysis of Oncolytic Adenoviruses in Canine Patient Necropsy Samples Treated with Cellular Virotherapy
Yazar:: Ana Gómez, ve diğerleri
Baskı/Yayın Bilgisi: (2020-09-01)

A versatile system for receptor-mediated gene delivery permits increased entry of DNA into target cells, enhanced delivery to the nucleus and elevated rates of transgene expression
Yazar:: Fisher, KD, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Adenovirus: teaching an old dog new tricks.
Yazar:: Seymour, L, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

An in silico approach uncovering the competency of oncolytic human adenovirus 52 for targeted breast cancer virotherapy
Yazar:: Muhammad Naveed, ve diğerleri
Baskı/Yayın Bilgisi: (2024-11-01)

Lactoferrin Retargets Human Adenoviruses to TLR4 to Induce an Abortive NLRP3-Associated Pyroptotic Response in Human Phagocytes
Yazar:: Coraline Chéneau, ve diğerleri
Baskı/Yayın Bilgisi: (2021-05-01)

Retargeted oncolytic adenovirus displaying a single variable domain of camelid heavy-chain-only antibody in a fiber protein
Yazar:: Elisabeth A van Erp, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

Oncolytic virotherapy: combining first-rate science with an unmet clinical need.
Yazar:: Seymour, L
Baskı/Yayın Bilgisi: (2011)